Cover Image
市場調查報告書

轉染試劑、設備的全球市場預測 2021年:磷酸鈣、脂轉染、樹狀聚合物、電穿孔、細胞核轉染、腺病毒、逆轉錄病毒、腺結合病毒 (AAV)

Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 334121
出版日期 內容資訊 英文 212 Pages
訂單完成後即時交付
價格
Back to Top
轉染試劑、設備的全球市場預測 2021年:磷酸鈣、脂轉染、樹狀聚合物、電穿孔、細胞核轉染、腺病毒、逆轉錄病毒、腺結合病毒 (AAV) Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021
出版日期: 2017年01月13日 內容資訊: 英文 212 Pages
簡介

全球轉染試劑、設備市場規模,預計從2016年到2021年的預測期間內以7.5%的年複合成長率發展,從2016年的7億1,540萬美元到2021年達到10億2,000萬美元。

本報告提供全球轉染試劑、設備的市場相關調查,試劑、設備種類與概要,市場成長的各種影響因素及市場機會分析,產品、手法的市場分析及市場成長預測,各地區的趨勢,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球轉染技術市場
  • 轉染技術市場:各應用 & 地區
  • 地區概要:轉染技術市場
  • 轉染技術市場:各產品
  • 轉染技術市場:各終端用戶

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 轉染技術市場:各產品

  • 簡介
  • 試劑
  • 設備、器具

第7章 轉染技術市場:各手法

  • 簡介
  • 生物化學的手法
    • 脂轉染
      • 優點
      • 缺點
    • 磷酸鈣
    • DEAE-聚葡萄糖
    • 樹狀聚合物
  • 物理的手法
    • 電穿孔
      • 優點
      • 缺點
    • 細胞核轉染
    • 其他
      • Sonoporation
      • 遺傳基因槍
      • Magnetofection
      • Optoinjection
  • 病毒的手法
    • 腺病毒
    • 逆轉錄病毒
    • 腺結合病毒 (AAV)

第8章 轉染技術市場:各用途

  • 簡介
  • 生物醫學的研究
    • 基因表現的研究
    • 癌症研究
    • 基因轉殖模式
  • 蛋白質生成
  • 藥物輸送

第9章 轉染技術市場:各終端用戶

  • 簡介
  • 大學 & 研究機關
  • 醫藥品 & 生物科技企業

第10章 轉染技術市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 其他的歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 其他 (RoW)
    • 南美
    • 中東、非洲

第11章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
  • 協定、合作、策略性聯盟
  • 新產品的投入
  • 擴張
  • 收購
  • 其他策略

第12章 企業簡介 (概要,產品與服務,財務,策略及發展趨勢)

  • THERMO FISHER SCIENTIFIC, INC. (LIFE TECHNOLOGIES)
  • PROMEGA CORPORATION
  • QIAGEN N.V.
  • F. HOFFMANN-LA ROCHE LTD
  • BIO-RAD LABORATORIES INC.
  • MAXCYTE, INC.
  • LONZA GROUP
  • MERCK KGAA
  • POLYPLUS TRANSFECTION SA
  • MIRUS BIO LLC.

第13章 附錄

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 3562

"The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021."

Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology & biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.

In 2016, the reagents segment is expected to account for the largest share of the market, by product. The biochemical method segment is expected to account for the largest share of the market, by method. The academic & research institutes segment is expected to account for the largest share of the market, by end user. The biomedical research segment is expected to account for the largest share of the market, by application.

In 2016, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, with emphasis on India, China, and Japan. Growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidence, and favorable regulatory framework.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopted various strategies such as agreements, collaborations and partnerships, new product launches, expansions, and acquisitions to increase their presence and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the transfection reagents and equipment market

  • By Company Type: Tier 1: 56%, Tier 2: 34%, and Tier 3: 10%
  • By Designation: Director Level: 28%, C-level: 19%, and Others: 53%
  • By Region: North America: 27%, Europe: 27%, APAC: 30%, and RoW: 16%

The prominent players in the global transfection reagents and equipment market include Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). These companies held a dominant position in the market mainly due to their well-established presence in the field of genomics, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players in the market include Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).

Research Coverage:

The report provides a picture of the transfection reagents and equipment market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, method, end user, application, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the transfection reagents and equipment market. The report analyzes the transfection reagents and equipment market, by product, method, end user, application, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the transfection reagents and equipment market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transfection methods across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the transfection technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transfection reagents and equipment market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. MARKET FORECAST METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL TRANSFECTION TECHNOLOGIES MARKET
  • 4.2. TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION & REGION
  • 4.3. GEOGRAPHIC SNAPSHOT: TRANSFECTION TECHNOLOGIES MARKET
  • 4.4. TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016 VS. 2021)
  • 4.5. TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021(USD MILLION)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Technological advancements in transfection technology
        • 5.2.1.1.1. CRISPR-Cas9
        • 5.2.1.1.2. CAR-T
        • 5.2.1.1.3. Three Dimension (3D) transfection technology
      • 5.2.1.2. Global alliances among leading research institutes to trigger drug discovery
      • 5.2.1.3. Increase in R&D spending and research activities by pharmaceutical and biotech companies
      • 5.2.1.4. Growing research activities in cell science
      • 5.2.1.5. Increase in demand for synthetic genes
      • 5.2.1.6. Rising incidence of cancer worldwide
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Selective effectiveness of transfection reagents
      • 5.2.2.2. Home brew reagents restrict sale of commercial kits
      • 5.2.2.3. High cost of transfection reagents
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Large-scale transfections
      • 5.2.3.2. High-growth opportunities in asian market
        • 5.2.3.2.1. India
        • 5.2.3.2.2. China
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Transfection in hard-to-transfect cells
      • 5.2.4.2. Cytotoxicity in transfection - a major concern

6. TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS
  • 6.3. EQUIPMENT

7. TRANSFECTION TECHNOLOGIES MARKET, BY METHOD

  • 7.1. INTRODUCTION
  • 7.2. BIOCHEMICAL METHODS
    • 7.2.1. LIPOFECTION
      • 7.2.1.1. Advantages
      • 7.2.1.2. Disadvantages
    • 7.2.2. CALCIUM PHOSPHATE
      • 7.2.2.1. Advantages
      • 7.2.2.2. Disadvantages
    • 7.2.3. DEAE-DEXTRAN
      • 7.2.3.1. Advantages
      • 7.2.3.2. Disadvantages
    • 7.2.4. DENDRIMERS
      • 7.2.4.1. Advantages
      • 7.2.4.2. Disadvantages
  • 7.3. PHYSICAL
    • 7.3.1. ELECTROPORATION
      • 7.3.1.1. Advantages
      • 7.3.1.2. Disadvantages
    • 7.3.2. NUCLEOFECTION
      • 7.3.2.1. Advantages
      • 7.3.2.2. Disadvantages
    • 7.3.3. OTHER METHODS
      • 7.3.3.1. Sonoporation
      • 7.3.3.2. Genegun
        • 7.3.3.2.1. Advantages
        • 7.3.3.2.2. Disadvantages
      • 7.3.3.3. Magnetofection
        • 7.3.3.3.1. Advantages
        • 7.3.3.3.2. Disadvantages
      • 7.3.3.4. Optoinjection
        • 7.3.3.4.1. Advantages
        • 7.3.3.4.2. Disadvantages
  • 7.4. VIRAL METHODS
    • 7.4.1. ADENOVIRUSES
    • 7.4.2. RETROVIRUSES
    • 7.4.3. ADENOASSOCIATED VIRUSES (AAV)

8. TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. BIOMEDICAL RESEARCH
    • 8.2.1. GENE EXPRESSION STUDIES
    • 8.2.2. CANCER RESEARCH
    • 8.2.3. TRANSGENIC MODELS
  • 8.3. PROTEIN PRODUCTION
  • 8.4. THERAPEUTIC DELIVERY

9. TRANSFECTION TECHNOLOGIES MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. ACADEMICS & RESEARCH INSTITUTES
  • 9.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. TRANSFECTION TECHNOLOGIES MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Increase in bio-based drug research
      • 10.2.1.2. Growing demand for protein-based therapeutics triggers the growth of U.S. market
      • 10.2.1.3. Increasing funding for biotechnology and for development of protein-based biologics
      • 10.2.1.4. Conferences/meetings/symposiums/workshops
    • 10.2.2. CANADA
      • 10.2.2.1. Government support for development of protein drugs is expected to drive the market for transfection technologies
      • 10.2.2.2. Increasing investments by the canadian government on regenerative medicine to drive market growth
      • 10.2.2.3. Increasing funding for genome engineering in Canada likely to boost transfection technologies market
  • 10.3. EUROPE
    • 10.3.1. GERMANY
      • 10.3.1.1. Growing biotech industry and research funding in germany
      • 10.3.1.2. Collaboration among bio-pharmaceutical and biotechnology companies for the development of new vaccines is likely to drive the market growth
      • 10.3.1.3. Conferences and meetings/workshops in Germany
      • 10.3.1.4. Availability of funding for life science research in Germany
    • 10.3.2. U.K.
      • 10.3.2.1. 10,000 genome project initiative in U.K.
      • 10.3.2.2. Initiative to increase R&D investments in U.K.
    • 10.3.3. REST OF EUROPE
      • 10.3.3.1. Growing biotechnology and pharma industry in Italy
      • 10.3.3.2. Focus on research in Spain
      • 10.3.3.3. Investments and funding for life sciences to drive the transfection technologies market
      • 10.3.3.4. Growing research investments in Sweden & Denmark
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
      • 10.4.1.1. Rise in biomedical research in Japan
    • 10.4.2. CHINA
      • 10.4.2.1. Chinese government initiatives for life sciences R&D likely to boost the market
      • 10.4.2.2. Industry initiative to boost transfection technology market in China
    • 10.4.3. INDIA
      • 10.4.3.1. Booming pharmaceutical and biotechnology industries
      • 10.4.3.2. Development of bio-clusters in India
    • 10.4.4. REST OF ASIA-PACIFIC
      • 10.4.4.1. Federal collaborations in Australia
      • 10.4.4.2. Funding for research on proteomics and genomics in Australia
      • 10.4.4.3. Rising pharmaceutical and biotechnology R&D activities in South Korea
      • 10.4.4.4. Government support for strong academic and commercial R&D activities in Taiwan
      • 10.4.4.5. Genome Asia 100k initative
  • 10.5. REST OF THE WORD (ROW)
    • 10.5.1. LATIN AMERICA
      • 10.5.1.1. Increasing investment in Brazil and Mexico
      • 10.5.1.2. Brazil: investment in research and innovation centers and conferences & workshops
    • 10.5.2. MIDDLE EAST & AFRICA
      • 10.5.2.1. Increasing focus of major pharmaceutical, biopharmaceutical, and biotechnology firms in Saudi Arabia and the United Arab Emirates (UAE) and African regions
      • 10.5.2.2. Genetic testing and genomic analysis in the Middle East

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
    • 11.2.1. INTRODUCTION
    • 11.2.2. THERMO FISHER SCIENTIFIC INC.
    • 11.2.3. PROMEGA CORPORATION
    • 11.2.4. F. HOFFMANN-LA ROCHE LTD
    • 11.2.5. QIAGEN N.V.
  • 11.3. COMPETITIVE SITUATION AND TRENDS
  • 11.4. AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
  • 11.5. NEW PRODUCT LAUNCHES
  • 11.6. EXPANSIONS
  • 11.7. ACQUISITIONS
  • 11.8. OTHER STRATEGIES

12. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. THERMO FISHER SCIENTIFIC INC. (LIFE TECHNOLOGIES)
  • 12.2. PROMEGA CORPORATION
  • 12.3. QIAGEN N.V.
  • 12.4. F. HOFFMANN-LA ROCHE LTD
  • 12.5. BIO-RAD LABORATORIES, INC.
  • 12.6. MAXCYTE, INC.
  • 12.7. LONZA GROUP LTD.
  • 12.8. MERCK KGAA
  • 12.9. POLYPLUS-TRANSFECTION SA
  • 12.10. MIRUS BIO LLC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. OTHER DEVELOPMENTS
    • 13.2.1. MAXCYTE INC.
    • 13.2.2. LONZA GROUP LTD.
    • 13.2.3. QIAGEN N.V.
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INDICATIVE LIST OF CELL-BASED RESEARCH STUDIES
  • TABLE 2: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 3: TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: TRANSFECTION INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 6: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 7: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: LIPOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CALCIUM PHOSPHATE METHOD, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: DEAE-DEXTRAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: DENDRIMER TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 13: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: ELECTROPORATION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NUCLEOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: OTHER PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: VIRAL SYSTEMS
  • TABLE 18: VIRAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 20: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 21: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR GENE EXPRESSION STUDIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CANCER RESEARCH, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR TRANSGENIC MODELS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: INDICATIVE LIST OF FEW RECOMBINANT PROTEINS, VACCINES FROM DIFFERENT CELL TYPES
  • TABLE 26: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PROTEIN PRODUCTION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: INDICATIVE LIST OF DRUG DELIVERY SYSTEMS FOR VARIOUS DISEASE CONDITIONS
  • TABLE 28: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR THERAPEUTIC DELIVERY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 30: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 41: LIST OF MONOCLONAL ANTIBODIES APPROVED BY FDA IN 2015
  • TABLE 42: INDICATIVE LIST OF UPCOMING EVENTS IN THE U.S.
  • TABLE 43: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 45: U.S.: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: U.S.: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 50: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 51: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 52: CANADA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: CANADA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 55: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 65: INDICATIVE LIST OF UPCOMING EVENTS IN GERMANY
  • TABLE 66: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 68: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 71: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 73: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 75: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD, BY TYPE 2014-2021 (USD MILLION)
  • TABLE 76: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE 2014-2021 (USD MILLION)
  • TABLE 77: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 78: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 81: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 82: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 88: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 89: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 90: ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 93: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 95: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 96: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 97: JAPAN: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: JAPAN: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 100: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 102: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 103: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 104: CHINA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: CHINA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 107: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 109: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 110: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 111: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: INDIA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 114: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 116: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 117: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 118: REST OF ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: REST OF ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 120: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 121: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 123: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 124: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 125: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 128: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 130: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 2013-2016
  • TABLE 131: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 132: EXPANSIONS, 2013-2016
  • TABLE 133: ACQUISITIONS, 2013-2016
  • TABLE 134: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL TRANSFECTION TECHNOLOGIES MARKET
  • FIGURE 2: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN: GLOBAL TRANSFECTION TECHNOLOGIES MARKET
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD (2016)
  • FIGURE 9: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016-2021)
  • FIGURE 10: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021
  • FIGURE 11: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 14: BIOMEDICAL RESEARCH SEGMENT TO DOMINATE THE TRANSFECTION TECHNOLOGIES MARKET IN 2016
  • FIGURE 15: ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 16: REAGENTS SEGMENT IS PROJECTED TO ACCOUNT FOR THE LARGEST SHARE THROUGH 2021
  • FIGURE 17: ACADEMIC & RESEARCH INSTITUTES SEGMENT IS EXPECTED TO DOMINATE THE MARKET THROUGH 2021
  • FIGURE 18: MARKET DYNAMICS
  • FIGURE 19: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2016-2021 (USD MILLION)
  • FIGURE 20: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2016 VS. 2021 (USD MILLION)
  • FIGURE 21: TRANSFECTION TECHNOLOGIES MARKET: BY APPLICATION
  • FIGURE 22: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 23: TRANSFECTION TECHNOLOGIES MARKET: BY REGION, 2016-2021
  • FIGURE 24: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 25: EUROPE : TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 26: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 27: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, ARE THE MAJOR STRATEGIES ADOPTED BY THE KEY PLAYERS, 2013-2016
  • FIGURE 28: GLOBAL TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 29: AGREEMENTS,COLLABORATIONS, AND PARTNERSHIPS: KEY STRATEGY ADOPTED BY PLAYERS (2013-2016)
  • FIGURE 30: AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS, BY COMPANY (2013-2016)
  • FIGURE 31: NEW PRODUCT LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 32: EXPANSIONS, BY COMPANY (2013-2016)
  • FIGURE 33: ACQUISITION, BY COMPANY (2013-2016)
  • FIGURE 34: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 35: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 36: PROMEGA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 38: ROCHE: COMPANY SNAPSHOT
  • FIGURE 39: BIO-RAD LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 40: MAXCYTE INC.: COMPANY SNAPSHOT
  • FIGURE 41: LONZA GROUP: COMPANY SNAPSHOT
  • FIGURE 42: MERCK KGAA : COMPANY SNAPSHOT
  • FIGURE 43: SIGMA ALDRICH CORPORATION : COMPANY SNAPSHOT
Back to Top